A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice

Trial Profile

A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Budesonide (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms CORE Practice
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 09 Nov 2017 Planned End Date changed from 1 Feb 2018 to 1 Sep 2018.
    • 09 Nov 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2018.
    • 17 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top